Wang, Xu
Liu, Shuai
Sun, Yehui http://orcid.org/0000-0003-0215-6095
Yu, Xueliang
Lee, Sang M. http://orcid.org/0000-0001-7658-6229
Cheng, Qiang
Wei, Tuo http://orcid.org/0000-0002-2823-9721
Gong, Junyu
Robinson, Joshua http://orcid.org/0000-0002-6200-2904
Zhang, Di
Lian, Xizhen
Basak, Pratima
Siegwart, Daniel J. http://orcid.org/0000-0003-3823-1931
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB025192-01A1)
Cancer Prevention and Research Institute of Texas (RP190251)
U.S. Department of Health & Human Services | National Institutes of Health (T32GM127216, T32GM127216)
Article History
Received: 8 February 2022
Accepted: 7 July 2022
First Online: 31 October 2022
Competing interests
: The University of Texas System has filed patent applications related to the SORT technology, with some authors listed as co-inventors. D.J.S. is a co-founder/consultant to ReCode Therapeutics, which has licensed intellectual property from UT Southwestern. D.J.S. is on the Scientific Advisory Board of Tome Biosciences.
Free to read: This content has been made available to all.